litlas
Log inCreate account

Douglas A. Jabs

Active 1983–2025

Also published as
Douglas A Jabs
149
Papers
23,532
Citations
85
h-index
144
i10-index

Citations

Citations per year for Douglas A. Jabs1985: 1 citations1986: 2 citations1987: 4 citations1988: 15 citations1989: 19 citations1990: 10 citations1991: 13 citations1992: 27 citations1993: 32 citations1994: 29 citations1995: 43 citations1996: 22 citations1997: 23 citations1998: 43 citations1999: 49 citations2000: 46 citations2001: 62 citations2002: 79 citations2003: 72 citations2004: 83 citations2005: 85 citations2006: 83 citations2007: 90 citations2008: 90 citations2009: 88 citations2010: 142 citations2011: 97 citations2012: 101 citations2013: 160 citations2014: 94 citations2015: 132 citations2016: 112 citations2017: 112 citations2018: 78 citations2019: 500 citations2020: 411 citations2021: 652 citations2022: 383 citations2023: 242 citations2024: 497 citations2025: 208 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,353 citing papers, 28.6% of this breakdownUnited Kingdom: 405 citing papers, 8.6% of this breakdownItaly: 240 citing papers, 5.1% of this breakdownGermany: 220 citing papers, 4.6% of this breakdownChina: 207 citing papers, 4.4% of this breakdownFrance: 191 citing papers, 4% of this breakdownIndia: 176 citing papers, 3.7% of this breakdownAustralia: 142 citing papers, 3% of this breakdownNetherlands: 140 citing papers, 3% of this breakdownSpain: 139 citing papers, 2.9% of this breakdownJapan: 137 citing papers, 2.9% of this breakdownCanada: 116 citing papers, 2.4% of this breakdown
0%28.6%Other 26.8%

Institutions

Fields

  • Medicine87.8%
  • Biochemistry, Genetics and Molecular Biology5.1%
  • Immunology and Microbiology4.2%
  • Neuroscience0.6%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Dentistry0.3%
  • Other1.5%

Topics

  • Ocular Diseases and Behçet’s Syndrome18.1%
  • Retinal Diseases and Treatments6%
  • Retinal and Optic Conditions5%
  • Cytomegalovirus and herpesvirus research4.7%
  • Sarcoidosis and Beryllium Toxicity Research3.5%
  • Autoimmune and Inflammatory Disorders Research2.5%
  • Other60.2%

Coauthors

All papers

Open in search
  1. Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop

    Authors: Douglas A. Jabs, Robert B. Nussenblatt, James T. Rosenbaum - American Journal of Ophthalmology 2005 cited by 4,353

  2. Immunosuppression for the Uveitides

    Authors: Douglas A. Jabs - Ophthalmology 2017 cited by 196

  3. Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection

    Authors: Peter W. Hunt, Elizabeth Sinclair, Benigno Rodríguez, Carey L. Shive, Brian Clagett, Nicholas Funderburg, Janet Robinson, Yong Huang, Lorrie Epling, Jeffrey N. Martin, Steven G. Deeks, Curtis L. Meinert, Mark L. Van Natta, Douglas A. Jabs, Michael M. Lederman - The Journal of Infectious Diseases 2014 cited by 476

  4. Uveitis for the non-ophthalmologist

    Authors: Bryn M. Burkholder, Douglas A. Jabs - BMJ 2021 cited by 98

  5. Expert Panel Recommendations for the Use of Anti–Tumor Necrosis Factor Biologic Agents in Patients with Ocular Inflammatory Disorders

    Authors: Grace A. Levy-Clarke, Douglas A. Jabs, Russell W. Read, James T. Rosenbaum, Albert T. Vitale, Russell N. Van Gelder - Ophthalmology 2013 cited by 477

  6. Early Outpatient Treatment for Covid-19 with Convalescent Plasma

    Authors: David Sullivan, Kelly A. Gebo, Shmuel Shoham, Evan M. Bloch, Bryan Lau, Aarthi Shenoy, Giselle Mosnaim, Thomas J. Gniadek, Yuriko Fukuta, Bela Patel, Sonya L. Heath, Adam C. Levine, Barry Meisenberg, Emily S Spivak, Shweta Anjan, Moisés A. Huamán, Janis E. Blair, Judith S. Currier, James H. Paxton, Jonathan M. Gerber, Joann Petrini, Patrick Broderick, William Rausch, Marie Elena Cordisco, Jean Hammel, Benjamin Greenblatt, Valerie Cluzet, Daniel Cruser, Kevin Oei, Matthew Abinante, Laura L. Hammitt, Catherine G. Sutcliffe, Donald N. Forthal, Martin S. Zand, Edward R. Cachay, Jay S. Raval, Seble Kassaye, Emily Foster, Michael D. Roth, Christi E. Marshall, Anusha Yarava, Karen Lane, Nichol McBee, Amy L. Gawad, Nicky Karlen, Atika Singh, Daniel E. Ford, Douglas A. Jabs, Lawrence J. Appel, David Shade, Stephan Ehrhardt, Sheriza Baksh, Oliver Laeyendecker, Andrew Pekosz, Sabra L. Klein, Arturo Casadevall, Aaron A.R. Tobian, Daniel F. Hanley - New England Journal of Medicine 2022 cited by 269

  7. Randomized Comparison of Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Implant for Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment Trial

    Authors: John H. Kempen, Michael M. Altaweel, Janet T. Holbrook, Douglas A. Jabs, Thomas A. Louis, Elizabeth A. Sugar, Jennifer E. Thorne - Ophthalmology 2011 cited by 329

  8. Methotrexate for Ocular Inflammatory Diseases

    Authors: Sapna Gangaputra, Craig Newcomb, Teresa L. Liesegang, R. Oktay Kaçmaz, Douglas A. Jabs, Grace A. Levy-Clarke, Robert B. Nussenblatt, James T. Rosenbaum, Eric B. Suhler, Jennifer E. Thorne - Ophthalmology 2009 cited by 321

  9. Mycophenolate Mofetil for Ocular Inflammation

    Authors: Ebenezer Daniel, Jennifer E. Thorne, Craig Newcomb, Siddharth S. Pujari, R. Oktay Kaçmaz, Grace A. Levy-Clarke, Robert B. Nussenblatt, James T. Rosenbaum, Eric B. Suhler, C. Stephen Foster, Douglas A. Jabs, John H. Kempen - American Journal of Ophthalmology 2009 cited by 252

  10. Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema

    Authors: Jennifer E. Thorne, Elizabeth A. Sugar, Janet T. Holbrook, Alyce Burke, Michael M. Altaweel, Albert T. Vitale, Nisha R. Acharya, John H. Kempen, Douglas A. Jabs - Ophthalmology 2018 cited by 206

  11. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel

    Authors: Douglas A. Jabs, James T. Rosenbaum, C. Stephen Foster, Gary N. Holland, Glenn J. Jaffe, James S. Louie, Robert B. Nussenblatt, E. Richard Stiehm, Howard H. Tessler, Russell N. Van Gelder, Scott M. Whitcup, David E. Yocum - American Journal of Ophthalmology 2000 cited by 993

  12. Development of Classification Criteria for the Uveitides

    Authors: Douglas A. Jabs, Peter McCluskey, Neal Oden, Alan G. Palestine, Jan S. Peterson, Sophia M. Saleem, Jennifer E. Thorne, Brett E. Trusko - American Journal of Ophthalmology 2021 cited by 106

  13. Classification Criteria for Behçet Disease Uveitis

    Authors: Douglas A. Jabs, Andrew D. Dick, James P. Dunn, Michal Kramer, Peter McCluskey, Neal Oden, Annabelle A. Okada, Alan G. Palestine, Russell W. Read, Jennifer E. Thorne, Brett E. Trusko, Steven Yeh - American Journal of Ophthalmology 2021 cited by 75

  14. Classification Criteria for Multifocal Choroiditis With Panuveitis

    Authors: Douglas A. Jabs, Antoine P. Brezin, Ralph D. Levinson, Peter McCluskey, Neal Oden, Alan G. Palestine, Russell W. Read, Jennifer E. Thorne, Brett E. Trusko, Albert Vitale, Susan E. Wittenberg - American Journal of Ophthalmology 2021 cited by 58

  15. Azathioprine for Ocular Inflammatory Diseases

    Authors: Sirichai Pasadhika, John H. Kempen, Craig Newcomb, Teresa L. Liesegang, Siddharth S. Pujari, James T. Rosenbaum, Jennifer E. Thorne, C. Stephen Foster, Douglas A. Jabs, Grace A. Levy-Clarke, Robert B. Nussenblatt, Eric B. Suhler - American Journal of Ophthalmology 2009 cited by 252

  16. Risk of Cataract Development among Children with Juvenile Idiopathic Arthritis-Related Uveitis Treated with Topical Corticosteroids

    Authors: Jennifer E. Thorne, Fasika A. Woreta, James P. Dunn, Douglas A. Jabs - Ophthalmology 2010 cited by 236

  17. Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis

    Authors: John H. Kempen, Michael M. Altaweel, Janet T. Holbrook, Elizabeth A. Sugar, Jennifer E. Thorne, Douglas A. Jabs - JAMA 2017 cited by 126

  18. Classification Criteria for Birdshot Chorioretinitis

    Authors: Douglas A. Jabs, Antoine P. Brezin, Ralph D. Levinson, Peter McCluskey, Neal Oden, Alan G. Palestine, Russell W. Read, Jennifer E. Thorne, Brett E. Trusko, Albert Vitale, Susan E. Wittenberg - American Journal of Ophthalmology 2021 cited by 73

  19. Classification Criteria for Cytomegalovirus Retinitis

    Authors: Douglas A. Jabs, Rubens Belfort, Bahram Bodaghi, Elizabeth Graham, Gary N. Holland, Susan L. Lightman, Neal Oden, Alan G. Palestine, Justine R. Smith, Jennifer E. Thorne, Brett E. Trusko, Russell N. Van Gelder - American Journal of Ophthalmology 2021 cited by 71

  20. Classification Criteria for Punctate Inner Choroiditis

    Authors: Douglas A. Jabs, Antoine P. Brezin, Ralph D. Levinson, Susan L. Lightman, Peter McCluskey, Neal Oden, Alan G. Palestine, Narsing A. Rao, Jennifer E. Thorne, Brett E. Trusko, Albert Vitale, Susan E. Wittenberg - American Journal of Ophthalmology 2021 cited by 54

  21. Classification Criteria for Syphilitic Uveitis

    Authors: Douglas A. Jabs, Rubens Belfort, Bahram Bodaghi, Elizabeth Graham, Gary N. Holland, Susan L. Lightman, Neal Oden, Alan G. Palestine, Justine R. Smith, Jennifer E. Thorne, Brett E. Trusko - American Journal of Ophthalmology 2021 cited by 42

  22. Comparison of Antimetabolite Drugs as Corticosteroid-Sparing Therapy for Noninfectious Ocular Inflammation

    Authors: Anat Galor, Douglas A. Jabs, Henry A. Leder, Sanjay Kedhar, James P. Dunn, George B. Peters, Jennifer E. Thorne - Ophthalmology 2008 cited by 216

  23. Approach to the Diagnosis of the Uveitides

    Authors: Douglas A. Jabs, Jacqueline Busingye - American Journal of Ophthalmology 2013 cited by 160

  24. Methods for Identifying Long-Term Adverse Effects of Treatment in Patients with Eye Diseases: The Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study

    Authors: John H. Kempen, Ebenezer Daniel, Sapna Gangaputra, Kurt Dreger, Douglas A. Jabs, R. Oktay Kaçmaz, Siddharth S. Pujari, Fahd Anzaar, C. Stephen Foster, Kathy J. Helzlsouer, Grace A. Levy-Clarke, Robert B. Nussenblatt, Teresa L. Liesegang, James T. Rosenbaum, Eric B. Suhler - Ophthalmic Epidemiology 2008 cited by 126